Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CAMK1 |
| Upstream (Parents) |
|---|
| (<<) CCL15///CCL14 → CAMK1 |
| (<<) NFIC → CAMK1 |
| (<<) C19orf66 → CAMK1 |
| (<<) CTSF → CAMK1 |
| (<<) EVL → CAMK1 |
| Downstream (Children) |
|---|
| CAMK1 → GAD1 (>>) |
| CAMK1 → DMBT1 (>>) |
| CAMK1 → PHLPP1 (>>) |
| CAMK1 → SIM2 (>>) |
| CAMK1 → LAG3 (>>) |
| CAMK1 → SPTBN1 (>>) |
| CAMK1 → SRPK2 (>>) |
| CAMK1 → KIAA1731 (>>) |
| CAMK1 → STMN3 (>>) |
| CAMK1 → MAPK12 (>>) |
| CAMK1 → EPM2A (>>) |
| CAMK1 → PDE11A (>>) |
| CAMK1 → RNLS (>>) |
| CAMK1 → CPT1A (>>) |
| CAMK1 → FLJ11710 (>>) |
| CAMK1 → STOML1 (>>) |
| CAMK1 → AIM1 (>>) |
| CAMK1 → PDCD6 (>>) |
